Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Team BL - Stock Market Today Live, October 26: Stocks to watch: Raymond, RailTel, KEC Intl, Honasa, BL Kashyap, Lupin, Orchid Pharma, Gland Pharma
Stock Market Today Live, October 26: Stocks to watch: Raymond, RailTel, KEC Intl, Honasa, BL Kashyap, Lupin, Orchid Pharma, Gland Pharma
BusinessLine –

Sensex Today, Nifty 50 | Stock Market Live Updates: Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 26th October 2026. Markets fell for a fourth consecutive session on Friday, weighed…

thehindubusinessline.com - Stocks to watch October 26: Raymond, RailTel, KEC Intl, Honasa, BL Kashyap, Lupin, Orchid Pharma, Gland Pharma among 15 stocks to be in focus
Stocks to watch October 26: Raymond, RailTel, KEC Intl, Honasa, BL Kashyap, Lupin, Orchid Pharma, Gland Pharma among 15 stocks to be in focus
BusinessLine –

The Board of Directors Raymond Ltd has approved a proposal to change the name of the company to Raymond Aerospace, Defence & Engineering Ltd. RailTel Corporation of India Ltd has received the Letter of Intent (LoI) from Munitions India Ltd for Rs…

thehindubusinessline.com - Torrent Pharma eyes semaglutide launch in Brazil in 6-9 months
Torrent Pharma eyes semaglutide launch in Brazil in 6-9 months
BusinessLine –

Torrent Pharmaceuticals plans to launch semaglutide in Brazil over the next six to nine months, as the drugmaker seeks to expand its presence in a market where revenues grew 38 per cent in the September quarter, Managing Director Aman Mehta said.

fool.com - Reuben Gregg Brewer - Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead
Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead
The Motley Fool –

Biotech companies are high-risk, high-reward investments. Usually, a biotech has just one drug in development, and if it gets that drug to market, you win. If the drug doesn't work out, you lose. You don't have to make binary bets like that if you…

marketbeat.com - Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Stock Has Average Price Target of $6.67 According to Analysts
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Stock Has Average Price Target of $6.67 According to Analysts
MarketBeat –

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) has received an average recommendation of 'Moderate Buy' from the six research firms that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst…

businessinsider.com - Truman Dickerson - After a long, strange trip, this CEO is close to taking a psilocybin pill to market
After a long, strange trip, this CEO is close to taking a psilocybin pill to market
Business Insider –

In 2022, Kabir Nath had a cushy executive job at a pharmaceutical firm that developed anti-psychotic medication. Then he got a call from a scrappy upstart with a patent on a synthetic version of psilocybin — the active ingredient in magic…

statnews.com - Andrew Joseph - At ESMO, AstraZeneca's cancer pursuits get a showcase
At ESMO, AstraZeneca's cancer pursuits get a showcase
STAT –

MADRID — For AstraZeneca, a major oncology conference here this weekend has been a sign of how the company's cancer work is steamrolling ahead, with highlights from a mix of old standbys and new molecules that could expand its armament of…

swissinfo.ch - swissinfo.ch - Data security breaches rise in 2026
Data security breaches rise in 2026
www.swissinfo.ch –

There were 343 such incidents throughout 2025. However, the actual number of incidents is likely to be significantly higher, as there are a large number of unreported cases, he said in an interview with the Swiss German weekly Sonntagsblick.

bloomberg.com - Samie Modak - Investors Flee India Small-Caps as Margin Calls Come Knocking
Investors Flee India Small-Caps as Margin Calls Come Knocking
Bloomberg –

This article is for subscribers only. I'm Samie Modak in Mumbai, where bears seem to be tightening their grip on stocks. The benchmark Nifty 50 Index capped a fourth straight session of losses on Friday as higher oil prices weighed on sentiment.

zerohedge.com - Tyler Durden - Bill Gates Faces Court Over Claims COVID Jabs Were 'Lethal Biological Weapons
Bill Gates Faces Court Over Claims COVID Jabs Were 'Lethal Biological Weapons
Zero Hedge –

In a packed courtroom in Leeuwarden, the official COVID story is being put on trial as Dutch plaintiffs demand personal liability from Bill Gates, Pfizer CEO Albert Bourla, former Prime Minister Mark Rutte and others for what their lawyer calls a…

seekingalpha.com - Albert Anthony - Armour Residential REIT (ARR): Sidelined Again As A High-Yield Idea With MBS Volatility
Armour Residential REIT (ARR): Sidelined Again As A High-Yield Idea With MBS Volatility
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

econotimes.com - Naomi Calder - Stakeholders Urge Employers to Support Women Experiencing Menopause at Work
Stakeholders Urge Employers to Support Women Experiencing Menopause at Work
EconoTimes –

Vanguard reported that stakeholders at the launch of Menopause At Work Africa urged public and private employers to adopt workplace policies for women experiencing perimenopause and menopause, citing stigma around discussing symptoms. Erefa Coker…

rediff.com - Text Feed - Bristlecone's 24% Growth Fuels Billion-Dollar Valuation Ambition
Bristlecone's 24% Growth Fuels Billion-Dollar Valuation Ambition
Rediff.com –

Discover how Mahindra Group's Bristlecone is leveraging a 24 per cent year-on-year growth and strategic AI investments to pursue a billion-dollar valuation in the competitive supply chain services market. Bristlecone, a Mahindra Group firm…

marketbeat.com - Top Growth Stocks Worth Watching - October 25th
Top Growth Stocks Worth Watching - October 25th
MarketBeat –

Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Jersey Mike's are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth…

thehindu.com -  The Hindu Bureau - KSSP supports distribution of generic drugs for SMA patients in Keralam
KSSP supports distribution of generic drugs for SMA patients in Keralam
The Hindu –

Updated - October 25, 2026 01:27 pm IST - Kozhikode Subscribe to The Hindu @ Just ₹1* Subscribe to The Hindu @ Just $4.99 *Offer only for new subscribers The Kerala Sastra Sahitya Parishad (KSSP) has supported the Kerala Health Department's…

Receive a Daily briefing on Pharma Industry News

Get Started